A simple method to account for skin dose enhancement during treatment planning of VMAT treatments of patients in contact with immobilization equipment

一种用于在VMAT治疗计划中考虑与固定设备接触的患者皮肤剂量增强的简便方法

阅读:1

Abstract

PURPOSE: The ability to accurately predict skin doses and thereby design radiotherapy treatments that balance the likelihood of skin reactions against other treatment objectives is especially important when hypofractionated prescription regimes are used. However, calculations of skin dose provided by many commercial radiotherapy treatment planning systems are known to be inaccurate, especially if the presence of immobilization equipment is not accurately taken into account. This study proposes a simple method by which the accuracy of skin dose calculations can be substantially improved, to allow informed evaluation of volumetric modulated arc therapy (VMAT) treatment plans. METHOD: A simple method was developed whereby dose calculation is split into grid regions, each with a correction factor which determines MU scaling for skin dose calculation. Correction factors were derived from film measurements made using a geometrically simple phantom in partial contact with a vacuum immobilization device. This method was applied to two different test treatments, planned for delivery to a humanoid phantom with a hypofractionated stereotactic body radiotherapy technique, and results were verified using film measurements of surface dose. RESULTS: Compared to the measured values, calculations of skin dose volumes corresponding to different grade tissue reactions were greatly improved through use of the method employed in this study. In some cases, the accuracy of skin dose evaluation improved by 76% and brought values to within 3% of those measured. CONCLUSION: The method of skin dose calculation in this study is simple, can be made as accurate as the user requires and is applicable for various immobilization systems. This concept has been verified through use on SBRT lung treatment plans and will aid clinicians in predicting skin response in patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。